Main Specifications

• Askina Calgitrol patented matrix formulation combines calcium alginate and silver alginate with 10% of bonded water. In contact with exudate, the alginate matrix forms a soft gel allowing the liberation of silver ions.
• Askina Calgitrol Ag is a technologically advanced wound dressing that incorporates the barrier effectiveness of ionic silver with the absorption capabilities of calcium alginate and polyurethane foam.
• Highly efficient
• No activation needed: ready to use
• Immediately active – significant reduction of bacterial load within first 30 minutes
• Active against broad spectrum of microorganisms, including MRSA
• Sustainable antimicrobial effectiveness for up to 7 days
• Atraumatic removal
• Non-staining
• Infected or critically colonized, moderately to heavily exuding wounds: stage I-IV pressure ulcers, venous and arterial leg ulcers, diabetic foot ulcers, 2^nd degree burns, traumatic wounds and donor sites.
• Contraindication this product should not be used on patients with a known sensitivity to alginates or silver; should not be used where the presence of metals is contraindicated. Contraindicated for ulcers resulting from infection, such as tuberculosis, syphilis, or deep fungal infection, and for third degree burns. Do not use if pack is damaged or opened.